Twiist
Device Automated Insulin Delivery Device
PDI 00198617101002
General payments
$472,007
Research payments
$4,340,060
Through program year 2025, $472,007 in general payments and $4,340,060 in research payments were reported against Twiist (Automated Insulin Delivery Device).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $469,223 | 10,302 |
| 2025 | Research | $4,340,060 | 3,749 |
| 2024 | General | $2,784 | 5 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 94 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 50 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
10,307 general · 3,749 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.